At ASCO, I saw a lot of new innovations that are accelerating the urgency to change how we think about genomics in cancer prevention and treatment.
Our latest offerings underscore our commitment to the genetics community, high-risk program outcomes, and continued innovation in precision...
This year we were excited to see growing momentum around personalized prevention & early detection of cancer. Read on for our top 3 three takeaways...
Your curated February 2023 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
Your curated January 2023 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity, &...
One of the greatest sources of untapped revenue lies in oncology, where an unmet need for cancer prevention also promises to drive innovation...
Your curated December 2022 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
CancerIQ data shows 2 in 5 patients who undergo comprehensive cancer risk assessment and genetic testing require a change in medical management.
Your curated November 2022 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
Last week, the CancerIQ team & I headed to HLTH 2022, the NSGC Annual Conference, & the AACR Special Conference. I'm feeling inspired and with a full...